The Acute Effects of Coffee on Glucose Metabolism

Type 2 Diabetes Clinical Trial

Official title:

Human Trial of the Acute Effects of Coffee on Glucose Metabolism

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00950898
• Other study ID #: 07-020
• Status: Completed
• Phase: N/A
• First received: July 31, 2009
• Last updated: July 31, 2009
• Start date: November 2006
• Est. completion date: June 2007

Study information

• Verified date: July 2009
• Source: Brooklyn College of the City University of New York
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study was to determine the acute effects of decaffeinated coffee, caffeinated coffee and caffeine on glucose metabolism in humans

Recruitment information / eligibility

• Status: Completed
• Enrollment: 11
• Est. completion date: June 2007
• Est. primary completion date: June 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• healthy young males

• nonsmokers

• moderate alcohol users

Exclusion Criteria:

• not on any medications that could alter glucose metabolism

• no history of blood disorders

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science

Related Conditions & MeSH terms

• Type 2 Diabetes

Intervention

Other:
• decaff
2 mugs of decaffeinated coffee
• caffcoff
2 mugs of caffeinated coffee
• caffeine
2 mugs of hot water containing caffeine
• placebo
2 mugs of hot water

Locations

Country	Name	City	State
United States	Brooklyn College of the City University of New York	Brooklyn	New York

Sponsors (1)

Lead Sponsor	Collaborator
Brooklyn College of the City University of New York

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	plasma glucose levels		0, 10, 30, 60, 90, and 120 minutes.	No
Secondary	plasma insulin		0, 10, 30, 60, 90, and 120 minutes	No